date:Sep 10, 2012
ade on the firms websites.
The FDA has taken these actions because companies may not sell new drugs unless the drugs have been tested by the sponsor and approved by FDA, and they may not make false or unsubstantiated claims about drugs they sell, said Dara A. Corrigan, the FDAs associate commissioner for regulatory affairs. Products with unapproved claims are dangerous because they may cause consumers to delay or avoid legitimate treatments.
Neuro Impact, NeuroPruTect, and Omega3PruTect have n